Cargando…

Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19

BACKGROUND: While a COVID-19 vaccine protects people from serious illness and death, it remains a concern when and how to lift the high-cost and strict non-pharmaceutical interventions (NPIs). This study examined the joint effect of vaccine coverage and NPIs on the control of local and sporadic resu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Jinhua, Zhu, Wenlong, Tian, Jie, Liu, Zhixi, Xu, Ao, Yao, Ye, Wang, Weibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959078/
https://www.ncbi.nlm.nih.gov/pubmed/35346382
http://dx.doi.org/10.1186/s40249-022-00960-6
_version_ 1784677071893561344
author Pan, Jinhua
Zhu, Wenlong
Tian, Jie
Liu, Zhixi
Xu, Ao
Yao, Ye
Wang, Weibing
author_facet Pan, Jinhua
Zhu, Wenlong
Tian, Jie
Liu, Zhixi
Xu, Ao
Yao, Ye
Wang, Weibing
author_sort Pan, Jinhua
collection PubMed
description BACKGROUND: While a COVID-19 vaccine protects people from serious illness and death, it remains a concern when and how to lift the high-cost and strict non-pharmaceutical interventions (NPIs). This study examined the joint effect of vaccine coverage and NPIs on the control of local and sporadic resurgence of COVID-19 cases. METHODS: Between July 2021 and January 2022, we collected the large-scale testing information and case number of imported COVID-19 patients from the website of the National Health Commission of China. A compartment model was developed to identify the level of vaccine coverage that would allow safe relaxation of NPIs, and vaccination strategies that can best achieve this level of coverage. We applied Monte Carlo simulation 50 000 times to remove random fluctuation effects and obtain fitted/predicted epidemic curve based on various parameters with 95% confidence interval at each time point. RESULTS: We found that a vaccination coverage of 50.4% was needed for the safe relaxation of NPIs, if the vaccine effectiveness was 79.3%. The total number of incidence cases under the key groups firstly strategy was 10(3) times higher than that of accelerated vaccination strategy. It needed 35 months to fully relax NPIs if the key groups firstly strategy was implemented, and 27 months were needed with the accelerated vaccination strategy. If combined the two strategies, only 8 months are needed to achieve the vaccine coverage threshold for the fully relaxation of NPIs. Sensitivity analyses results shown that the higher the transmission rate of the virus and the lower annual vaccine supply, the more difficult the epidemic could be under control. When the transmission rate increased 25% or the vaccination effectiveness rate decreased 20%, 33 months were needed to reduce the number of total incidence cases below 1000. CONCLUSIONS: As vaccine coverage improves, the NPIs can be gradually relaxed. Until that threshold is reached, however, strict NPIs are still needed to control the epidemic. The more transmissible SARS-CoV-2 variant led to higher resurgence probability, which indicates the importance of accelerated vaccination and achieving the vaccine coverage earlier. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40249-022-00960-6.
format Online
Article
Text
id pubmed-8959078
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89590782022-03-29 Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19 Pan, Jinhua Zhu, Wenlong Tian, Jie Liu, Zhixi Xu, Ao Yao, Ye Wang, Weibing Infect Dis Poverty Research Article BACKGROUND: While a COVID-19 vaccine protects people from serious illness and death, it remains a concern when and how to lift the high-cost and strict non-pharmaceutical interventions (NPIs). This study examined the joint effect of vaccine coverage and NPIs on the control of local and sporadic resurgence of COVID-19 cases. METHODS: Between July 2021 and January 2022, we collected the large-scale testing information and case number of imported COVID-19 patients from the website of the National Health Commission of China. A compartment model was developed to identify the level of vaccine coverage that would allow safe relaxation of NPIs, and vaccination strategies that can best achieve this level of coverage. We applied Monte Carlo simulation 50 000 times to remove random fluctuation effects and obtain fitted/predicted epidemic curve based on various parameters with 95% confidence interval at each time point. RESULTS: We found that a vaccination coverage of 50.4% was needed for the safe relaxation of NPIs, if the vaccine effectiveness was 79.3%. The total number of incidence cases under the key groups firstly strategy was 10(3) times higher than that of accelerated vaccination strategy. It needed 35 months to fully relax NPIs if the key groups firstly strategy was implemented, and 27 months were needed with the accelerated vaccination strategy. If combined the two strategies, only 8 months are needed to achieve the vaccine coverage threshold for the fully relaxation of NPIs. Sensitivity analyses results shown that the higher the transmission rate of the virus and the lower annual vaccine supply, the more difficult the epidemic could be under control. When the transmission rate increased 25% or the vaccination effectiveness rate decreased 20%, 33 months were needed to reduce the number of total incidence cases below 1000. CONCLUSIONS: As vaccine coverage improves, the NPIs can be gradually relaxed. Until that threshold is reached, however, strict NPIs are still needed to control the epidemic. The more transmissible SARS-CoV-2 variant led to higher resurgence probability, which indicates the importance of accelerated vaccination and achieving the vaccine coverage earlier. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40249-022-00960-6. BioMed Central 2022-03-26 /pmc/articles/PMC8959078/ /pubmed/35346382 http://dx.doi.org/10.1186/s40249-022-00960-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Pan, Jinhua
Zhu, Wenlong
Tian, Jie
Liu, Zhixi
Xu, Ao
Yao, Ye
Wang, Weibing
Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19
title Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19
title_full Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19
title_fullStr Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19
title_full_unstemmed Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19
title_short Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19
title_sort vaccination as an alternative to non-drug interventions to prevent local resurgence of covid-19
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959078/
https://www.ncbi.nlm.nih.gov/pubmed/35346382
http://dx.doi.org/10.1186/s40249-022-00960-6
work_keys_str_mv AT panjinhua vaccinationasanalternativetonondruginterventionstopreventlocalresurgenceofcovid19
AT zhuwenlong vaccinationasanalternativetonondruginterventionstopreventlocalresurgenceofcovid19
AT tianjie vaccinationasanalternativetonondruginterventionstopreventlocalresurgenceofcovid19
AT liuzhixi vaccinationasanalternativetonondruginterventionstopreventlocalresurgenceofcovid19
AT xuao vaccinationasanalternativetonondruginterventionstopreventlocalresurgenceofcovid19
AT yaoye vaccinationasanalternativetonondruginterventionstopreventlocalresurgenceofcovid19
AT wangweibing vaccinationasanalternativetonondruginterventionstopreventlocalresurgenceofcovid19